Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Companion diagnostics drive precision oncology growth and accessibility, says GlobalData

Companion diagnostic (CDx) tests play a pivotal role in modern oncology by identifying specific biomarkers that guide personalized cancer treatments. These tests, such as HER2 testing in breast cancer, determine eligibility for targeted therapies like trastuzumab. The evolving landscape of CDx tests is marked by decreasing costs, driven by technological advancements and economies of scale, […]
Read more

Volkswagen’s $5 billion bet on Rivian gets influencer attention on X, reveals GlobalData

Volkswagen (VW) and US-based electric vehicle (EV) startup Rivian Automotive have emerged as trending companies among the influencers on social media platform “X,” following the German automaker’s announcement of a strategic investment of up to $5 billion in Rivian. This partnership is perceived as mutually beneficial wherein Volkswagen secures access to Rivian’s advanced software-defined vehicle […]
Read more

Medical tourism gains prominence in filing documents of companies, finds GlobalData

Medical tourism has been gaining momentum and it is also evident from companies’ discussions that it presents a big opportunity. An in-depth analysis of the filing documents reveals that companies are focusing on the needs of international patients, including access to skilled healthcare professionals, advanced treatments, and world-class facilities, reveals the Company Filing Analytics Database […]
Read more

Humanoid robotics conversations surge 80% on social media platform X during H1 2024, reveals GlobalData

The field of humanoid robotics is evolving rapidly, merging sophisticated AI with precise mechanics to create robots that closely emulate human behaviors. Influencers on social media platform “X” are actively discussing on how these technological advancements could transform various sectors, which led to 80% rise in conversations during the first half (H1) of 2024 (January-June). […]
Read more

Everest Medicines Nefecon to transform IgAN treatment in China and Asia, says GlobalData

China-based Everest Medicines has recently launched Nefecon (budesonide DR) to treat primary immunoglobulin A nephropathy (IgAN) in China. It is the first approved medicine for IgAN by China’s National Medical Products Administration (NMPA). It represents an innovative treatment option for IgAN patients with more rapid disease progression compared to the American and European populations, says […]
Read more

FDA approval of Verona’s Ohtuvayre to transform US COPD market for severe exacerbators, says GlobalData

Following the Food and Drug Administration’s (FDA) approval of Verona Pharma’s Ohtuvayre (ensifentrine) yesterday evening in the US: Asiyah Nawab, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “Ohtuvayre, a first-in-class dual phosphodiesterase (PDE) 3/4 inhibitor, has great potential to dominate the market for moderate to severe exacerbators with chronic […]
Read more

Oil and gas industry embraces circular economy to combat plastic pollution, says GlobalData

The circular economy involves recycling, reusing, and repurposing of products to extend their usable lifetime. Among the oil and gas industry’s conventional products, plastic is the most relevant to the circular economy. Increasing demand for circular economy solutions in the oil and gas industry, especially regarding plastics, presents several long-term opportunities for companies. Companies can […]
Read more

Fisker bankruptcy highlights struggles in balancing competitive pricing and sustainability, reveals GlobalData

Fisker bankruptcy filing has ignited fervent discussions among influencers on the social media platform “X”, drawing attention to the challenges and opportunities within the electric vehicle (EV) industry. Influencers are critically examining the sustainability of pricing strategies following Fisker’s drastic price reductions and bankruptcy filing, emphasizing the challenges faced by new entrants in scaling production […]
Read more

US card payments market to grow by 5% in 2024, forecasts GlobalData

The US card payments market is forecast to grow by 5% in 2024 to reach $10.6 trillion, supported by high consumer preference for electronic payments, according to GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that card payment value in US registered a growth of 12.3% in 2022, driven by the […]
Read more

FDA approval of CAPVAXIVE will enhance protection against pneumococcal disease in older adults, says GlobalData

The FDA has approved Merck’s CAPVAXIVE (pneumococcal 21-valent conjugate vaccine, originally known as V116), for the prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults aged 18 years and older. This is the first pneumococcal vaccine that is specifically designed to protect against serotypes which particularly infect older adults. The vaccine will likely become […]
Read more

Top 20 global payment giants thrive despite economic challenges, rake in $236 billion in 2023, reveals GlobalData

Amidst expansionary monetary policy, geopolitical uncertainties, and soaring inflation, the global payments industry continued to thrive in 2023. The top 20 public payment companies saw their revenues rise by 3.5% to $236 billion, reveals GlobalData, a leading data and analytics company. The US payment companies dominated the list with the top four – American Express, […]
Read more

Fixed communication services revenue in Malaysia to grow at 0.7% CAGR during 2023-2028, forecasts GlobalData

The fixed communication services revenue in Malaysia is expected to increase at a compound annual growth rate (CAGR) of 0.7% from $1.87 billion in 2023 to $1.94 billion in 2028, supported by the fixed broadband service segment, forecasts GlobalData, a leading data and analytics company. GlobalData’s Malaysia Fixed Communications Forecast (Q1 2024) reveals that the […]
Read more

TAVR treatment remains low in bicuspid aortic valve stenosis patients, finds GlobalData

Transcatheter aortic valve replacement (TAVR) has revolutionized the management of aortic valve stenosis (AS), providing a less invasive alternative to traditional surgical aortic valve replacement (SAVR). Initially approved for high-risk surgical patients, TAVR’s indications have expanded to include intermediate and even low-risk patients. However, its application in patients with bicuspid aortic valve (BAV) disease presents […]
Read more
1 … 56 57 58 59 60 … 206